Reduced Expression of Chl1 gene Impairs Insulin Secretion by Down-Regulating the Expression of Key Molecules of β-cell Function

Abstract

Silencing of Chl1 gene expression has been previously reported to reduce insulin secretion. Nevertheless, the mechanism underlying this effect remains unclear. In this study, we performed a serial of studies to investigate how Chl1 affects insulin secretion in INS-1 cells. RNA-sequencing was used to investigate the expression of CHL1 in human adipose, liver, muscle, and human islets. Silencing of Chl1 in INS-1 cells was done to assess its impact on the insulin secretion, content, cell viability, and apoptosis. In addition, gene set enrichment analysis (GSEA) was performed to identify possible molecular signatures that associate with Chl1 expression silencing.

RNA sequencing data revealed a high expression of CHL1 in pancreatic islets and adipose tissues compared to liver and muscles tissues. Diabetic islets exhibited a lower expression of CHL1 as compared to non-diabetic islets. CHL1 expression was found to correlate positively with insulin secretory index, GLP1R but inversely with HbA_1c and BMI. Silencing of Chl1 in INS-1 cells markedly reduced insulin content and secretion. The expression of key molecules of β-cell function including Insulin, Pdx1, Gck, Glut2, and Insrβ was down-regulated in Chl1-silenced cells at transcriptional and translational levels. Cell viability, apoptosis, and proliferation rate were not affected. GSEA showed that the insulin-signaling pathway was influenced in Chl1-silenced cells. Silencing of Chl1 impairs β-cell function by disrupting the activity of key signaling pathways of importance for insulin biosynthesis and secretion.

Key words

diabetes - insulin secretion - Chl1 - INS-1 (832/31) - gene expression microarray - human islets - GSEA.

Publication History

Received: 08 July 2019
Received: 09 September 2019

Accepted: 16 September 2019

Article published online:
15 October 2019

• References

• 1 Demyanenko GP, Halberstadt AI, Rao RS. et al. CHL1 cooperates with PAK1–3 to regulate morphological differentiation of embryonic cortical neurons. Neurosci 2010; 165: 107-115
• 2 Hillenbrand R, Molthagen M, Montag D. et al. The close homologue of the neural adhesion molecule L1 (CHL1): Patterns of expression and promotion of neurite outgrowth by heterophilic interactions. Eur J Neurosci 1999; 11: 813-826
• 3 Buhusi M, Midkiff BR, Gates AM. et al. Close homolog of L1 is an enhancer of integrin-mediated cell migration. J Biol Chem 2003; 278: 25024-25031
• 4 Leshchyns’ ka I, Sytnyk V. Reciprocal interactions between cell adhesion molecules of the immunoglobulin superfamily and the cytoskeleton in neurons. Front Cell Dev Biol 2016; 4: 9
• 5 Shoukier M, Fuchs S, Schwaibold E. et al. Microduplication of 3p26. 3 in nonsyndromic intellectual disability indicates an important role of CHL1 for normal cognitive function. Neuropediatrics 2013; 44: 268-271
• 6 Montag-Sallaz M, Baarke A, Montag D. Aberrant neuronal connectivity in CHL1-deficient mice is associated with altered information processing-related immediate early gene expression. J Neurobiol 2003; 57: 67-80
• 7 Irintchev A, Koch M, Needham LK. et al. Impairment of sensorimotor gating in mice deficient in the cell adhesion molecule L1 or its close homologue, CHL1. Brain research 2004; 1029: 131-134
• 8 Senchenko VN, Krasnov GS, Dmitriev AA. et al. Differential expression of CHL1 gene during development of major human cancers. PloS one 2011; 6: e15612
• 9 Huang X, Zhu L-l, Zhao T. et al. CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway. Mol Cell Neurosci 2011; 46: 296-307
• 10 Taneera J, Lang S, Sharma A. et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 2012; 16: 122-134
• 11 Fadista J, Vikman P, Laakso EO. et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc Natl Acad Sci USA 2014; 111: 13924-13929
• 12 Taneera J, Fadista J, Ahlqvist E. et al. Identification of novel genes for glucose metabolism based upon expression pattern in human islets and effect on insulin secretion and glycemia. Hum Mol Genet 2014; 24: 1945-1955
• 13 Hamoudi RA, Appert A, Ye H. et al. Differential expression of NF-κB target genes in MALT lymphoma with and without chromosome translocation: Insights into molecular mechanism. Leukemia 2010; 24: 1487
• 14 Butt MA, Pye H, Haidry RJ. et al. Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugate. Oncotarget 2017; 8: 25080
• 15 Ritchie ME, Phipson B, Wu D. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic acids Res 2015; 43: e47-e47
• 16 Jonsson A, Isomaa B, Tuomi T. et al. A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin secretion. Diabetes 2009; 58: 2409-2413
• 17 Bramswig NC, Everett LJ, Schug J. et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest 2013; 123: 1275-1284
• 18 Saxena V, Orgill D, Kohane I. Absolute enrichment: gene set enrichment analysis for homeostatic systems. Nucleic acids Res 2006; 34: e151-e151
• 19 Schmid RS, Maness PF. L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Cur Opi Neurobiol 2008; 18: 245-250
• 20 Ligthart S, van Herpt TT, Leening MJ. et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol 2016; 4: 44-51
• 21 Oh JY, Sung YA, Lee H. The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Diabetic Med 2013; 30: 436-442
• 22 Olofsson CS, Håkansson J, Salehi A. et al. Impaired insulin exocytosis in neural cell adhesion molecule−/− mice due to defective reorganization of the submembrane F-actin network. Endocrinology 2009; 150: 3067-3075
• 23 Dunér P, Al-Amily IM, Soni A. et al. Adhesion G protein-coupled receptor G1 (ADGRG1/GPR56) and pancreatic β-cell function. J Clin Endocrinol Metab 2016; 101: 4637-4645
• 24 Esni F, Täljedal I-B, Perl A-K. et al. Neural cell adhesion molecule (N-CAM) is required for cell type segregation and normal ultrastructure in pancreatic islets. J Cell Biol 1999; 144: 325-337
• 25 Chen S, Mantei N, Dong L. et al. Prevention of neuronal cell death by neural adhesion molecules L1 and CHL1. J Neurobiol 1999; 38: 428-439
• 26 Yang HJ, Xia YY, Wang L. et al. A novel role for neural cell adhesion molecule in modulating insulin signaling and adipocyte differentiation of mouse mesenchymal stem cells. J Cell Sci 2011; jcs. 085340
• 27 Voight BF, Scott LJ, Steinthorsdottir V. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genet 2010; 42: 579
• 28 Vionnet N, Stoffel M, Takeda J. et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 721
• 29 Wang J, Gu W, Chen C. Knocking down insulin receptor in pancreatic beta cell lines with lentiviral-small hairpin RNA reduces glucose-stimulated insulin secretion via decreasing the gene expression of insulin, GLUT2 and Pdx1. Int J Mol Sci 2018; 19: 985
• 30 Salehi A, Qader SS, Grapengiesser E. et al. Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility. Diabetes 2005; 54: 2126-2131